We found that wild-type TRIM16+/+ mice developed smaller melanoma lesions with skin carcinogen treatment (**P = 0.0073) compared to either TRIM16 keratinocyte knockout genotype mice (Fig. 3c). This evidence concerns the gene TRIM16 and melanoma.